Mrv0541 06101416172D 17 18 0 0 0 0 999 V2000 2.0399 -1.8215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7511 3.1151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7570 -0.8092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3130 -0.4004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8839 -0.9816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4186 1.8052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7043 -1.0679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7511 2.2901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5483 -0.2280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1636 1.0206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8537 0.3531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1893 -0.4004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.0332 0.4394 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.0837 1.8052 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.3386 1.0206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.2721 -0.1417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.6486 0.3531 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 7 1 1 0 0 0 0 7 5 2 0 0 0 0 8 2 1 0 0 0 0 8 6 1 0 0 0 0 9 5 1 0 0 0 0 10 6 2 0 0 0 0 12 7 1 0 0 0 0 12 11 2 0 0 0 0 13 9 2 0 0 0 0 13 11 1 0 0 0 0 14 8 2 0 0 0 0 15 10 1 0 0 0 0 15 11 1 0 0 0 0 15 14 1 0 0 0 0 16 3 1 0 0 0 0 16 9 1 0 0 0 0 17 4 1 0 0 0 0 17 10 1 0 0 0 0 M END > DB08991 > drugbank > COC1=CC(C)=NN1C1=NC(C)=CC(OC)=N1 > InChI=1S/C11H14N4O2/c1-7-5-9(16-3)13-11(12-7)15-10(17-4)6-8(2)14-15/h5-6H,1-4H3 > RHAXSHUQNIEUEY-UHFFFAOYSA-N > C11H14N4O2 > 234.2545 > 234.111675712 > 5 > 31 > 8.877139043656993e-06 > 24.793522446793965 > 1 > 0 > 0 > 1 > 4-methoxy-2-(5-methoxy-3-methyl-1H-pyrazol-1-yl)-6-methylpyrimidine > 1.56 > 1.445486329666666 > -2.32 > 0 > 0 > 2 > 0 > 1.9637847293317994 > 62.06 > 62.7062 > 3 > 1 > 1.13e+00 g/l > tetrahydrofolic acid > 0 > DB08991 > experimental > Epirizole > 4-methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine; Epirizol; Epirizole; Epirizolum; Mepirizol; Methopyrimazole; Polihexanid > Karmarte; Mebron > Epirizole hydrochloride $$$$